These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34163906)

  • 41. Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design.
    Xue X; Yu H; Yang H; Xue F; Wu Z; Shen W; Li J; Zhou Z; Ding Y; Zhao Q; Zhang XC; Liao M; Bartlam M; Rao Z
    J Virol; 2008 Mar; 82(5):2515-27. PubMed ID: 18094151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300.
    Davis DA; Bulut H; Shrestha P; Yaparla A; Jaeger HK; Hattori SI; Wingfield PT; Mieyal JJ; Mitsuya H; Yarchoan R
    mBio; 2021 Aug; 12(4):e0209421. PubMed ID: 34399606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In Silico Identification of New Anti-SARS-CoV-2 Main Protease (M
    Onyango H; Odhiambo P; Angwenyi D; Okoth P
    J Trop Med; 2022; 2022():3697498. PubMed ID: 36263438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease.
    Choudhury C
    J Biomol Struct Dyn; 2021 Jul; 39(10):3733-3746. PubMed ID: 32452282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential of NO donor furoxan as SARS-CoV-2 main protease (M
    Al-Sehemi AG; Pannipara M; Parulekar RS; Patil O; Choudhari PB; Bhatia MS; Zubaidha PK; Tamboli Y
    J Biomol Struct Dyn; 2021 Sep; 39(15):5804-5818. PubMed ID: 32643550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crystal Structure of Feline Infectious Peritonitis Virus Main Protease in Complex with Synergetic Dual Inhibitors.
    Wang F; Chen C; Liu X; Yang K; Xu X; Yang H
    J Virol; 2016 Feb; 90(4):1910-7. PubMed ID: 26656689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Se-S Bond Formation in the Covalent Inhibition Mechanism of SARS-CoV-2 Main Protease by Ebselen-like Inhibitors: A Computational Study.
    Parise A; Romeo I; Russo N; Marino T
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-Based Identification of Naphthoquinones and Derivatives as Novel Inhibitors of Main Protease M
    Santos LH; Kronenberger T; Almeida RG; Silva EB; Rocha REO; Oliveira JC; Barreto LV; Skinner D; Fajtová P; Giardini MA; Woodworth B; Bardine C; Lourenço AL; Craik CS; Poso A; Podust LM; McKerrow JH; Siqueira-Neto JL; O'Donoghue AJ; da Silva Júnior EN; Ferreira RS
    J Chem Inf Model; 2022 Dec; 62(24):6553-6573. PubMed ID: 35960688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, SARS-CoV-2 main protease inhibition, molecular docking and in silico ADME studies of furanochromene-quinoline hydrazone derivatives.
    Shellenberger BM; Basile ON; Cassel J; Olsen MR; Salvino JM; Montaner LJ; Tietjen I; Henry GE
    Bioorg Med Chem Lett; 2024 Apr; 102():129679. PubMed ID: 38423371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease.
    Frecer V; Miertus S
    RSC Adv; 2020 Nov; 10(66):40244-40263. PubMed ID: 35520818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigating novel thiazolyl-indazole derivatives as scaffolds for SARS-CoV-2 M
    Airas J; Bayas CA; N'Ait Ousidi A; Ait Itto MY; Auhmani A; Loubidi M; Esseffar M; Pollock JA; Parish CA
    Eur J Med Chem Rep; 2022 Apr; 4():100034. PubMed ID: 37519829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How Reproducible Are QM/MM Simulations? Lessons from Computational Studies of the Covalent Inhibition of the SARS-CoV-2 Main Protease by Carmofur.
    Giudetti G; Polyakov I; Grigorenko BL; Faraji S; Nemukhin AV; Krylov AI
    J Chem Theory Comput; 2022 Aug; 18(8):5056-5067. PubMed ID: 35797455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and In Silico Investigation of Isatin-Based Schiff Bases as Potential Inhibitors for Promising Targets against SARS-CoV-2.
    Esam Z; Akhavan M; Lotfi M; Bekhradnia A
    ChemistrySelect; 2022 Dec; 7(46):e202201983. PubMed ID: 36718466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In-silico pharmacophoric and molecular docking-based drug discovery against the Main Protease (Mpro) of SARS-CoV-2, a causative agent COVID-19.
    Haider Z; Subhani MM; Farooq MA; Ishaq M; Khalid M; Akram MN; Khan RSA; Niazi AK
    Pak J Pharm Sci; 2020 Nov; 33(6):2697-2705. PubMed ID: 33867348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CL
    Alamri MA; Tahir Ul Qamar M; Mirza MU; Bhadane R; Alqahtani SM; Muneer I; Froeyen M; Salo-Ahen OMH
    J Biomol Struct Dyn; 2021 Aug; 39(13):4936-4948. PubMed ID: 32579061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic.
    Fakhar Z; Faramarzi B; Pacifico S; Faramarzi S
    J Biomol Struct Dyn; 2021 Oct; 39(16):6171-6183. PubMed ID: 32741312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigating the promising SARS-CoV-2 main protease inhibitory activity of secoiridoids isolated from
    Al-Karmalawy AA; Alnajjar R; Elmaaty AA; Binjubair FA; Al-Rashood ST; Mansour BS; Elkamhawy A; Eldehna WM; Mansour KA
    J Biomol Struct Dyn; 2024 Aug; 42(13):6941-6953. PubMed ID: 37505066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Finding potent inhibitors for COVID-19 main protease (M
    Motiwale M; Yadav NS; Kumar S; Kushwaha T; Choudhir G; Sharma S; Singour PK
    J Biomol Struct Dyn; 2022 Mar; 40(4):1534-1545. PubMed ID: 33030102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure-Based Discovery of Novel Nonpeptide Inhibitors Targeting SARS-CoV-2 M
    Yang J; Lin X; Xing N; Zhang Z; Zhang H; Wu H; Xue W
    J Chem Inf Model; 2021 Aug; 61(8):3917-3926. PubMed ID: 34279924
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    Ram TS; Munikumar M; Raju VN; Devaraj P; Boiroju NK; Hemalatha R; Prasad PVV; Gundeti M; Sisodia BS; Pawar S; Prasad GP; Chincholikar M; Goel S; Mangal A; Gaidhani S; Srikanth N; Dhiman KS
    J Ayurveda Integr Med; 2022; 13(1):100413. PubMed ID: 33654345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.